Merck KGaA could now have a head start in the race to market Precem-TcT, which could become the first widely approved ADC in ...

Gibson, Dunn & Crutcher and White & Case have emerged as the foremost legal advisers for mergers and acquisitions (M&A) in ...

At AAO 2025, EyePoint Pharmaceuticals presented updates on its investigational therapy EYP-1901 (vorolanib) for DME and wAMD.

H. Lundbeck and Contera Pharma have announced a research partnership in new oligonucleotide-based therapies for neurological ...

The complex and costly journey of oncology drug development is reliant on robust and comprehensive clinical data. Early-stage ...

The US FDA has granted approval for Roche's Gazyva/ Gazyvaro to treat adult patients with active LN who are on standard ...

Dermatology is thriving with innovation, from smart oral drugs to gene-therapy based fixes for rare skin diseases and skin ...

Morgan Stanley has secured the leading position as a financial adviser by deal value in South & Central America's M&A sector.

JP Morgan and Rothschild & Co have emerged as the top mergers and acquisitions (M&A) financial advisers in the Middle East & ...

In the realm of M&A, Skadden, Arps, Slate, Meagher & Flom, and Veirano Advogados have emerged as the top legal advisers in ...

J&J will now explore Rybrevant's efficacy and safety in a Phase III trial in first-line, EGFR-driven HNSCC and colorectal ...

Sanofi’s teplizumab, which is already FDA-approved to delay the onset of stage 3 type 1 diabetes, has been included on the ...